Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
125.00
-0.59 (-0.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Nasdaq, S&P 500 Futures Indicate Weak Opening For Wall Street: Benefit Of Lowering Recession Risk Comes With Sticky Inflation Threat, Says Economist
February 17, 2023
Index futures indicate U.S. markets are on track for a weak opening in continuation of Thursday's decline after hawkish comments from Federal Reserve officials and a higher than expected producers'...
Via
Benzinga
Tesla, DraftKings, DoorDash, Moderna, Stem: Why These Five Stocks Are Drawing Investors' Attention Today
February 16, 2023
Via
Benzinga
After-Hours Alert: Why Moderna Stock Is Diving
February 16, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading lower in Thursday's after-hours session after the company released interim Phase 3 safety and immunogenicity
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate
February 16, 2023
Via
ACCESSWIRE
5 Value Stocks In The Healthcare Sector
February 13, 2023
Via
Benzinga
Is Moderna Stock a Buy Now?
February 03, 2023
The company is starting the year on a strong note.
Via
The Motley Fool
A Bull Market Is Coming. To Prepare, Take Warren Buffett's Advice.
February 16, 2023
Quality and price are two key elements to keep in mind.
Via
The Motley Fool
Moderna's CEO To Appear Before Senate On Quadrupling COVID-19 Vaccine Prices
February 16, 2023
Moderna Inc's (NASDAQ: MRNA) CEO, Stéphane Bancel, will testify next month on its plans to raise the price of its COVID-19 vaccine in front of the Senate.
Via
Benzinga
7 Hot Healthcare Stocks With the Potential to Outperform
February 15, 2023
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.
Via
InvestorPlace
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
You won't find Novavax's latest bad news trumpeted in a press release.
Via
The Motley Fool
Candy? Flowers? These Top Stocks Offer You Something Even Sweeter
February 14, 2023
These stocks may reward you over time.
Via
The Motley Fool
Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling
February 13, 2023
The Nasdaq closed lower on Friday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
These Cheap Growth Stocks Could Supercharge Your Portfolio
February 12, 2023
All of these players are cheap today considering their growth potential.
Via
The Motley Fool
Moderna Stock Getting Closer To Key Technical Benchmark
February 10, 2023
On Friday, biotech Moderna stock received an upgrade to its Relative Strength (RS) Rating, to 72 from 69 a day earlier.
Via
Investor's Business Daily
'I Think It's Peaked Already': Jim Cramer On This Stock Up 22% Over Past Month
February 10, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Okta Inc (NASDAQ: OKTA) CEO Todd McKinnon has "got to pivot first.
Via
Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
The landscape has shifted dramatically in the COVID-19 vaccine market.
Via
The Motley Fool
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via
Benzinga
1 Company Bucks the Office REIT Trend With Higher Rents and Earnings
February 06, 2023
Life sciences companies may be more immune to work-from-home shifts.
Via
The Motley Fool
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
Danaher Corporation (NYSE: DHR) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT).
Via
Benzinga
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In January: Where Do SPY, Tesla, Apple And Ford Rank?
February 05, 2023
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Via
Benzinga
3 No-Brainer Growth Stocks to Buy in 2023
February 03, 2023
These stocks all fell by double digits last year.
Via
The Motley Fool
Why Personalis Shares Are Trading Higher Today
February 03, 2023
Via
Benzinga
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
February 03, 2023
From
Personalis, Inc.
Via
Business Wire
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.
Via
InvestorPlace
Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
February 02, 2023
Via
ACCESSWIRE
The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023
February 01, 2023
For those seeking the best discounts in the tech-centered index, these are the most undervalued Nasdaq stocks to buy.
Via
InvestorPlace
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.
Via
MarketBeat
Exposures
COVID-19
Product Safety
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
Novavax shares sank 93% last year.
Via
The Motley Fool
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.